These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24903663)

  • 1. Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh.
    Chu HY; Steinhoff MC; Magaret A; Zaman K; Roy E; Langdon G; Formica MA; Walsh EE; Englund JA
    J Infect Dis; 2014 Nov; 210(10):1582-9. PubMed ID: 24903663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal.
    Chu HY; Tielsch J; Katz J; Magaret AS; Khatry S; LeClerq SC; Shrestha L; Kuypers J; Steinhoff MC; Englund JA
    J Clin Virol; 2017 Oct; 95():90-95. PubMed ID: 28903080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplacental Respiratory Syncytial Virus and Influenza Virus Antibody Transfer in Alaska Native and Seattle Mother-Infant Pairs.
    Chu HY; Newman KL; Englund JA; Cho S; Bull C; Lacombe K; Carlin K; Bulkow LR; Rudolph K; DeByle C; Berner J; Klejka J; Singleton R
    J Pediatric Infect Dis Soc; 2021 Apr; 10(3):230-236. PubMed ID: 32369172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental Transfer of Respiratory Syncytial Virus Antibody Among HIV-Exposed, Uninfected Infants.
    Patel SM; Jallow S; Boiditswe S; Madhi SA; Feemster KA; Steenhoff AP; Arscott-Mills T; Muthoga C; Ajibola G; Shapiro R; Shah SS; Cunningham CK; Kelly MS
    J Pediatric Infect Dis Soc; 2020 Jul; 9(3):349-356. PubMed ID: 31549157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of respiratory syncytial virus IgG antibody dynamics in mother-infant pairs cohort.
    Yildiz M; Kara M; Sutcu M; Mese S; Demircili ME; Sivrikoz TS; Torun SH; Agacfidan A; Coban A; Unuvar E; Somer A
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1279-1286. PubMed ID: 32060753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypergammaglobulinemia and Impaired Transplacental Transfer of Respiratory Syncytial Virus Antibody in Papua New Guinea.
    Atwell JE; Thumar B; Formica MA; Robinson LJ; Walsh EE; King CL; Karron RA
    Pediatr Infect Dis J; 2019 Sep; 38(9):e199-e202. PubMed ID: 31408055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory Syncytial Virus (RSV) Neutralizing Antibodies at Birth Predict Protection from RSV Illness in Infants in the First 3 Months of Life.
    Buchwald AG; Graham BS; Traore A; Haidara FC; Chen M; Morabito K; Lin BC; Sow SO; Levine MM; Pasetti MF; Tapia MD
    Clin Infect Dis; 2021 Dec; 73(11):e4421-e4427. PubMed ID: 32463443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive Immunization Strategies to Prevent Severe Respiratory Syncytial Virus Infection Among Newborns and Young Infants.
    Suryadevara M
    J Pediatric Infect Dis Soc; 2024 Jul; 13(Supplement_2):S110-S114. PubMed ID: 38995085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies.
    Piedra PA; Jewell AM; Cron SG; Atmar RL; Glezen WP
    Vaccine; 2003 Jul; 21(24):3479-82. PubMed ID: 12850364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying maternally derived respiratory syncytial virus specific neutralising antibodies in a birth cohort from coastal Kenya.
    Nyiro JU; Sande C; Mutunga M; Kiyuka PK; Munywoki PK; Scott JA; Nokes DJ
    Vaccine; 2015 Apr; 33(15):1797-801. PubMed ID: 25725445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus-Specific Antibody, Viral Load, and Disease Severity in Respiratory Syncytial Virus Infection.
    Walsh EE; Wang L; Falsey AR; Qiu X; Corbett A; Holden-Wiltse J; Mariani TJ; Topham DJ; Caserta MT
    J Infect Dis; 2018 Jun; 218(2):208-217. PubMed ID: 29546402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired Transplacental Transfer of Respiratory Syncytial Virus-neutralizing Antibodies in Human Immunodeficiency Virus-infected Versus -uninfected Pregnant Women.
    Jallow S; Agosti Y; Kgagudi P; Vandecar M; Cutland CL; Simões EAF; Nunes MC; Suchard MS; Madhi SA
    Clin Infect Dis; 2019 Jun; 69(1):151-154. PubMed ID: 30561563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive protection against respiratory syncytial virus disease in infants: the role of maternal antibody.
    Englund JA
    Pediatr Infect Dis J; 1994 May; 13(5):449-53. PubMed ID: 8072835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Level of maternal antibodies against respiratory syncytial virus (RSV) nucleoprotein at birth and risk of RSV very severe lower respiratory tract infection.
    Receveur M; Ottmann M; Reynes JM; Eleouet JF; Galloux M; Receveur A; Ploin D; Fiorini S; Rivat N; Valette M; Lina B; Casalegno JS
    Influenza Other Respir Viruses; 2023 Jan; 17(1):e13025. PubMed ID: 36251946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological factors that may impair transplacental transfer of RSV antibodies: Implications for maternal immunization policy and research priorities for low- and middle-income countries.
    Atwell JE; Lutz CS; Sparrow EG; Feikin DR
    Vaccine; 2022 Jul; 40(32):4361-4370. PubMed ID: 35725783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplacental transfer of RSV antibody in Australian First Nations infants.
    Homaira N; Binks M; Walker G; Larter N; Clark K; Campbell M; McHugh L; Briggs N; Nyiro J; Stelzer-Braid S; Hu N; Macartney K; Snelling T; Omer SB; Rawlinson W; Andrews R; Jaffe A
    J Med Virol; 2022 Feb; 94(2):782-786. PubMed ID: 34633091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy?
    Munoz FM
    Curr Opin Infect Dis; 2015 Jun; 28(3):221-4. PubMed ID: 25918956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze.
    Stensballe LG; Ravn H; Kristensen K; Agerskov K; Meakins T; Aaby P; Simões EA
    J Allergy Clin Immunol; 2009 Feb; 123(2):398-403. PubMed ID: 19101023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the vaccination window for respiratory syncytial virus (RSV) using age-seroprevalence data for children in Kilifi, Kenya.
    Nyiro JU; Kombe IK; Sande CJ; Kipkoech J; Kiyuka PK; Onyango CO; Munywoki PK; Kinyanjui TM; Nokes DJ
    PLoS One; 2017; 12(5):e0177803. PubMed ID: 28531224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Placental Malaria and Hypergammaglobulinemia on Transplacental Transfer of Respiratory Syncytial Virus Antibody in Papua New Guinea.
    Atwell JE; Thumar B; Robinson LJ; Tobby R; Yambo P; Ome-Kaius M; Siba PM; Unger HW; Rogerson SJ; King CL; Karron RA
    J Infect Dis; 2016 Feb; 213(3):423-31. PubMed ID: 26238686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.